Retinoic acid-related orphan receptor RORβ, circadian rhythm abnormalities and tumorigenesis (Review)

International Journal of Molecular Medicine

Volumn 35, Issue 6, 2015, Pages 1493-1500

  Feng, Shujiong ^a   Xu, Song ^a   Wen, Zhenzhen ^a   Zhu, Yongliang ^a,b  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Circadian rhythm; Nuclear receptors; Retinoic acid related orphan receptor ; Tumorigenesis

Indexed keywords

RETINOIC ACID RECEPTOR BETA; RETINOID RELATED ORPHAN RECEPTOR BETA; RORB PROTEIN, HUMAN; TUMOR PROTEIN;

BONE DEVELOPMENT; CANCER PREVENTION; CARCINOGENESIS; CHEMICAL STRUCTURE; CIRCADIAN RHYTHM; GENOTYPE; HUMAN; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; TUMOR GROWTH; ANIMAL; CELL TRANSFORMATION; METABOLISM; NEOPLASMS; PATHOLOGY; PATHOPHYSIOLOGY; SLEEP DISORDER;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 2;

EID: 84928393274     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2155     Document Type: Review

References (72)

1. Solt LA, Griffin PR and Burris TP: Ligand regulation of retinoic acid receptor-related orphan receptors: implications for development of novel therapeutics. Curr Opin Lipidol 21: 204-211, 2010
2. Becker-André M, André E and DeLamarter JF: Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. Biochem Biophys Res Commun 194: 1371-1379, 1993
3. Carlberg C, Hooft van Huijsduijnen R, Staple JK, DeLamarter JF and Becker-André M: RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol Endocrinol 8: 757-770, 1994
4. Jetten AM and Ueda E: Retinoid-related orphan receptors (RORs): roles in cell survival, differentiation and disease. Cell Death Differ 9: 1167-1171, 2002
5. Jetten AM, Kurebayashi S and Ueda E: The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes. Prog Nucleic Acid Res Mol Biol 69: 205-247, 2001
6. Giguère V: Orphan nuclear receptors: from gene to function. Endocr Rev 20: 689-725, 1999
7. Gawlas K and Stunnenberg HG: Differential transcription of the orphan receptor RORbeta in nuclear extracts derived from Neuro2A and HeLa cells. Nucleic Acids Res 29: 3424-3432, 2001
8. Gawlas K and Stunnenberg HG: Differential binding and transcriptional behaviour of two highly related orphan receptors, ROR alpha(4) and ROR beta(1). Biochim Biophys Acta 1494: 236-241, 2000
9. Stehlin C, Wurtz JM, Steinmetz A, et al: X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation. EMBO J 20: 5822-5831, 2001
10. Sullivan AA and Thummel CS: Temporal profiles of nuclear receptor gene expression reveal coordinate transcriptional responses during Drosophila development. Mol Endocrinol 17: 2125-2137, 2003
11. Palli SR, Ladd TR and Retnakaran A: Cloning and characterization of a new isoform of Choristoneura hormone receptor 3 from the spruce budworm. Arch Insect Biochem Physiol 35: 33-44, 1997
12. Hiruma K and Riddiford LM: Differential control of MHR3 promoter activity by isoforms of the ecdysone receptor and inhibitory effects of E75A and MHR3. Dev Biol 272: 510-521, 2004
13. Flores MV, Hall C, Jury A, Crosier K and Crosier P: The zebrafish retinoid-related orphan receptor (ror) gene family. Gene Expr Patterns 7: 535-543, 2007
14. Jetten AM: Recent advances in the mechanisms of action and physiological functions of the retinoid-related orphan receptors (RORs). Curr Drug Targets Inflamm Allergy 3: 395-412, 2004
15. Solt LA, Kojetin DJ and Burris TP: The REV-ERBs and RORs: molecular links between circadian rhythms and lipid homeostasis. Future Med Chem 3: 623-638, 2011
16. Tosini G, Davidson AJ, Fukuhara C, Kasamatsu M and Castanon-Cervantes O: Localization of a circadian clock in mammalian photoreceptors. FASEB J 21: 3866-3871, 2007
17. Vogel MW, Sinclair M, Qiu D and Fan H: Purkinje cell fate in staggerer mutants: agenesis versus cell death. J Neurobiol 42: 323-337, 2000
18. Ino H: Immunohistochemical characterization of the orphan nuclear receptor ROR alpha in the mouse nervous system. J Histochem Cytochem 52: 311-323, 2004
19. Kang HS, Angers M, Beak JY, et al: Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism. Physiol Genomics 31: 281-294, 2007
20. André E, Gawlas K and Becker-André M: A novel isoform of the orphan nuclear receptor RORbeta is specifically expressed in pineal gland and retina. Gene 216: 277-283, 1998
21. Chow L, Levine EM and Reh TA: The nuclear receptor transcription factor, retinoid-related orphan receptor beta, regulates retinal progenitor proliferation. Mech Dev 77: 149-164, 1998
22. Baler R, Coon S and Klein DC: Orphan nuclear receptor RZRbeta: cyclic AMP regulates expression in the pineal gland. Biochem Biophys Res Commun 220: 975-978, 1996
23. Mühlbauer E, Bazwinsky-Wutschke I, Wolgast S, Labucay K and Peschke E: Differential and day-time dependent expression of nuclear receptors RORalpha, RORbeta, RORgamma and RXRalpha in the rodent pancreas and islet. Mol Cell Endocrinol 365: 129-138, 2013
24. André E, Conquet F, Steinmayr M, Stratton SC, Porciatti V and Becker-André M: Disruption of retinoid-related orphan receptor beta changes circadian behavior, causes retinal degeneration and leads to vacillans phenotype in mice. EMBO J 17: 3867-3877, 1998
25. Masana MI, Sumaya IC, Becker-André M and Dubocovich ML: Behavioral characterization and modulation of circadian rhythms by light and melatonin in C3H/HeN mice homozygous for the RORbeta knockout. Am J Physiol Regul Integr Comp Physiol 292: R2357-R2367, 2007
26. Stehlin-Gaon C, Willmann D, Zeyer D, et al: All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat Struct Biol 10: 820-825, 2003
27. Wärnmark A, Treuter E, Wright AP and Gustafsson JA: Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol Endocrinol 17: 1901-1909, 2003
28. Watanabe M, Yanagisawa J, Kitagawa H, et al: A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J 20: 1341-1352, 2001
29. Nishihara E, O'Malley BW and Xu J: Nuclear receptor coregulators are new players in nervous system development and function. Mol Neurobiol 30: 307-325, 2004
30. Kurebayashi S, Nakajima T, Kim SC, et al: Selective LXXLL peptides antagonize transcriptional activation by the retinoid-related orphan receptor RORgamma. Biochem Biophys Res Commun 315: 919-927, 2004
31. Greiner EF, Kirfel J, Greschik H, et al: Differential ligand-dependent protein-protein interactions between nuclear receptors and a neuronal-specific cofactor. Proc Natl Acad Sci USA 97: 7160-7165, 2000
32. Heery DM, Hoare S, Hussain S, Parker MG and Sheppard H: Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors. J Biol Chem 276: 6695-6702, 2001
33. Torchia J, Rose DW, Inostroza J, et al: The transcriptional co-Activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387: 677-684, 1997
34. Glass CK, Rose DW and Rosenfeld MG: Nuclear receptor coactivators. Curr Opin Cell Biol 9: 222-232, 1997
35. Gabriely G, Kama R, Gelin-Licht R and Gerst JE: Different domains of the UBL-UBA ubiquitin receptor, Ddi1/Vsm1, are involved in its multiple cellular roles. Mol Biol Cell 19: 3625-3637, 2008
36. Akashi M and Takumi T: The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol 12: 441-448, 2005
37. Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y and Littman DR: An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 5: 64-73, 2004
38. Liu H, Kim SY, Fu Y, et al: An isoform of retinoid-related orphan receptor beta directs differentiation of retinal amacrine and horizontal interneurons. Nat Commun 4: 1813, 2013
39. Roforth MM, Khosla S and Monroe DG: Identification of Rorβ targets in cultured osteoblasts and in human bone. Biochem Biophys Res Commun 440:768-773, 2013
40. Davidson B, Abeler VM, Forsund M, et al: Gene expression signatures of primary and metastatic uterine leiomyosarcoma. Hum Pathol 45: 691-700, 2014
41. Jetten AM: Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal 7: e003, 2009
42. Oh EC, Khan N, Novelli E, Khanna H, Strettoi E and Swaroop A: Transformation of cone precursors to functional rod photoreceptors by bZIP transcription factor NRL. Proc Natl Acad Sci USA 104: 1679-1684, 2007
43. Jia L, Oh EC, Ng L, et al: Retinoid-related orphan nuclear receptor RORbeta is an early-Acting factor in rod photoreceptor development. Proc Natl Acad Sci USA 106: 17534-17539, 2009
44. Roforth MM, Liu G, Khosla S and Monroe DG: Examination of nuclear receptor expression in osteoblasts reveals Rorbeta as an important regulator of osteogenesis. J Bone Miner Res 27: 891-901, 2012
45. Komori T, Yagi H, Nomura S, et al: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764, 1997
46. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I and Rifkin DB: Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int 51: 1376-1382, 1997
47. Risinger JI, Allard J, Chandran U, et al: Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasion. Front Oncol 3: 139, 2013
48. Matijevic T and Pavelic J: The dual role of TLR3 in metastatic cell line. Clin Exp Metastasis 28: 701-712, 2011
49. Kimmel AR: An orphan nuclear receptor finds a home. Mol Cell 37: 155-157, 2010
50. McDonald SL and Silver A: The opposing roles of Wnt-5a in cancer. Br J Cancer 101: 209-214, 2009
51. Lee JM, Kim IS, Kim H, et al: RORalpha attenuates Wnt/beta-catenin signaling by PKCalpha-dependent phosphorylation in colon cancer. Mol Cell 37: 183-195, 2010
52. Gery S and Koeffler HP: The role of circadian regulation in cancer. Cold Spring Harb Symp Quant Biol 72: 459-464, 2007
53. Kettner NM, Katchy CA and Fu L: Circadian gene variants in cancer. Ann Med 46: 208-220, 2014
54. Fu L and Kettner NM: The circadian clock in cancer development and therapy. Prog Mol Biol Transl Sci 119: 221-282, 2013
55. Ueda HR, Hayashi S, Chen W, et al: System-level identification of transcriptional circuits underlying mammalian circadian clocks. Nat Genet 37: 187-192, 2005
56. Shearman LP, Sriram S, Weaver DR, et al: Interacting molecular loops in the mammalian circadian clock. Science 288: 1013-1019, 2000
57. Reick M, Garcia JA, Dudley C and McKnight SL: NPAS2: an analog of clock operative in the mammalian forebrain. Science 293: 506-509, 2001
58. +-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 134: 329-340, 2008
59. Asher G, Gatfield D, Stratmann M, et al: SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 134: 317-328, 2008
60. Rana S and Mahmood S: Circadian rhythm and its role in malignancy. J Circadian Rhythms 8: 3, 2010
61. Pukkala E, Aspholm R, Auvinen A, et al: Cancer incidence among 10,211 airline pilots: a Nordic study. Aviat Space Environ Med 74: 699-706, 2003
62. Viswanathan AN, Hankinson SE and Schernhammer ES: Night shift work and the risk of endometrial cancer. Cancer Res 67: 10618-10622, 2007
63. Koppes LL, Geuskens GA, Pronk A, Vermeulen RC and de Vroome EM: Night work and breast cancer risk in a general population prospective cohort study in The Netherlands. Eur J Epidemiol 29: 577-584, 2014
64. Schernhammer ES, Laden F, Speizer FE, et al: Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 95: 825-828, 2003
65. Keith LG, Oleszczuk JJ and Laguens M: Circadian rhythm chaos: a new breast cancer marker. Int J Fertil Womens Med 46: 238-247, 2001
66. Zhu Y, Stevens RG, Hoffman AE, et al: Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysis. Chronobiol Int 28: 852-861, 2011
67. Shih MC, Yeh KT, Tang KP, Chen JC and Chang JG: Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR. Mol Carcinog 45: 732-740, 2006
68. Hwang-Verslues WW, Chang PH, Jeng YM, et al: Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy. Proc Natl Acad Sci USA 110: 12331-12336, 2013
69. Yang X, Wood PA, Oh EY, Du-Quiton J, Ansell CM and Hrushesky WJ: Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat 117: 423-431, 2009
70. Gery S, Virk RK, Chumakov K, Yu A and Koeffler HP: The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene 26: 7916-7920, 2007
71. Filipski E and Levi F: Circadian disruption in experimental cancer processes. Integr Cancer Ther 8: 298-302, 2009
72. Kumaki Y, Ukai-Tadenuma M, Uno KD, et al: Analysis and synthesis of high-Amplitude Cis-elements in the mammalian circadian clock. Proc Natl Acad Sci USA 105: 14946-14951, 2008.